A comparative study assessing the incidence and degree of hyperkalemia in patients on angiotensin-converting enzyme inhibitors versus angiotensin-receptor blockers
- 14 October 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Human Hypertension
- Vol. 36 (5), 485-487
- https://doi.org/10.1038/s41371-021-00625-1
Abstract
Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor blockers (ARB) are the most commonly prescribed anti-hypertensive medications in the United States, yet whether ACEI or ARB use is associated with a greater risk of hyperkalemia remains uncertain. Using real-world evidence from electronic health records, our study demonstrates that treatment with ACEI is associated with both a higher incidence and greater degree of hyperkalemia than treatment with ARB in adjusted models, especially in patients with chronic kidney disease. Providers should therefore consider this possible difference in hyperkalemia risk when choosing between ACEI and ARB therapy.This publication has 12 references indexed in Scilit:
- Big data and real-world data-based medicine in the management of hypertensionHypertension Research, 2020
- Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005–2016Hypertension, 2020
- Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial InfarctionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2017
- Hyperkalemia After Initiating Renin–Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) ProjectJournal of the American Heart Association, 2017
- Potassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handlingKidney International Supplements, 2016
- Role of Circadian Rhythms in Potassium HomeostasisSeminars in Nephrology, 2013
- Potassium Homeostasis and Renin-Angiotensin-Aldosterone System InhibitorsClinical Journal of the American Society of Nephrology, 2010
- A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockersTherapeutics and Clinical Risk Management, 2009
- Comparative effects on dynamic renal potassium excretion of ACE inhibition versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus.The Journal of Clinical Pharmacology, 2002
- ACE inhibition or angiotensin receptor blockade: Impact on potassium in renal failureKidney International, 2000